期刊文献+
共找到17篇文章
< 1 >
每页显示 20 50 100
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
1
作者 Yi Wang yuting yan +15 位作者 Dandan Shan Jiawen Chen Wei Liu Tingyu Wang Gang An WeiweiSui Wenyang Huang Wenjie Xiong Huimin Liu Qi Sun Huijun Wang Zhijian Xiao JianxiangWang Lugui Qiu Dehui Zou Shuhua Yi 《Cancer Biology & Medicine》 2025年第2期177-189,共13页
Objective:Our previous studies have indicated potentially higher proliferative activity of tumor cells in Chinese patients with mantle-cell lymphoma(MCL)than those in Western.Given the success and tolerability of R-DA... Objective:Our previous studies have indicated potentially higher proliferative activity of tumor cells in Chinese patients with mantle-cell lymphoma(MCL)than those in Western.Given the success and tolerability of R-DA-EDOCH immunochemotherapy in treating aggressive B-cell lymphomas,we designed a prospective,phase 3 trial to explore the efficacy and safety of alternating R-DA-EDOCH/R-DHAP induction therapy for young patients with newly diagnosed MCL.The primary endpoint was the complete remission rate(CRR)at the end of induction(EOI).Methods:A total of 55 patients were enrolled.The CRR at the EOI was 89.1%[95%confidence interval(CI)78%±96%],and the overall response rate was 98.1%(95%CI 90%±100%).Most patients with bone marrow involvement quickly attained minimal residual disease(MRD)negative status,with a 95.7%rate at the EOI.Results:The 3-year progression-free survival(PFS)and overall survival rates were 66.3%and 83.2%,respectively.No patients discontinued treatment because of adverse events.Univariate analysis identified pathologic morphology and TP53 mutations as risk factors for PFS.However,high tumor proliferative activity and certain cytogenetic abnormalities showed no significant adverse prognostic significance.Conclusions:Intensive therapy based on a high cytarabine dose and continuously administered EDOCH achieved a high MRDnegative rate and provides an optional induction choice for young patients with MCL with high-risk factors. 展开更多
关键词 Mantle cell lymphoma IMMUNOCHEMOTHERAPY high-risk factors minimal residual disease adverse events
暂未订购
修订的国际分期系统(R-ISS)对初诊多发性骨髓瘤患者预后评估价值及局限性 被引量:12
2
作者 樊慧守 刘佳慧 +12 位作者 毛雪涵 杜辰星 阎禹廷 王轶 隋伟薇 邓书会 王婷玉 傅明伟 李增军 邹德慧 赵耀中 邱录贵 安刚 《中国肿瘤临床》 CAS CSCD 北大核心 2019年第20期1074-1079,共6页
目的:探讨修订的国际分期系统(revised international staging system,R-ISS)在真实世界中对初诊多发性骨髓瘤(multiple myeloma,MM)患者预后评估价值及局限性。方法:回顾性分析2002年6月至2017年11月中国医学科学院血液病医院新诊断的... 目的:探讨修订的国际分期系统(revised international staging system,R-ISS)在真实世界中对初诊多发性骨髓瘤(multiple myeloma,MM)患者预后评估价值及局限性。方法:回顾性分析2002年6月至2017年11月中国医学科学院血液病医院新诊断的568例MM患者临床资料。所有患者均接受基于硼替佐米或沙利度胺/来那度胺为主的方案诱导治疗≥4个疗程。以ISS分期为对照,分析R-ISS分期的预后意义。考虑到R-ISSⅡ期的MM患者之间存在较大的异质性,本研究将R-ISSⅡ期患者分成四组:第1组患者ISSⅠ期伴有乳酸脱氢酶(lactate dehydrogenase,LDH)水平升高或高危遗传学异常;第2组患者ISSⅡ期无LDH水平升高及高危遗传学异常;第3组患者ISSⅡ期伴有LDH水平升高或高危遗传学异常;第4组患者ISSⅢ期无LDH水平升高和高危遗传学异常。在此分组条件下对这部分患者进行生存分析。结果:568例MM患者中,男性347例,女性221例,中位发病年龄56(25~83)岁,中位随访33(4~203)个月。采用R-ISS分期,Ⅰ、Ⅱ、Ⅲ期患者分别为59例(12%)、310例(62%)、130例(26%),中位总体生存(median overall survival,mOS)时间分别为142、86和40个月(χ~2=29.588,P<0.001);采用ISS分期,Ⅰ、Ⅱ和Ⅲ期患者分别为106例(19%)、210例(37%)和252例(44%),mOS时间分别为142、71和40个月(χ~2=22.099,P<0.001)。采用Cox回归分析,ISS分期Ⅲ期对Ⅰ期HR=2.903,P<0.001,ISS分期Ⅱ期对Ⅰ期HR=1.985,P=0.005;而R-ISS分期Ⅲ期对Ⅰ期HR=5.441,P<0.001,R-ISS分期Ⅱ期对Ⅰ期HR=2.844,P=0.003。R-ISS分期Ⅱ期的4组患者的mOS时间分别为126、83、49(95%CI:33~65)、65(95%CI:44~86)个月(P=0.131)。总体上,四组OS无显著性差异,但是第2组和第3组OS相比呈显著性差异(χ~2=4.916,P=0.027)。结论:R-ISS分期相对于ISS分期能够更好地区分MM患者预后。对于有髓外浸润、有1q21扩增、不同年龄分组(年龄≥65岁和年龄<65岁)、不同治疗方案(硼替佐米治疗组及沙利度胺治疗组)、不同染色体倍数(低二倍体、非低二倍体)的患者OS均具有较高的预后判断价值。但R-ISS分期同为Ⅱ期患者的生存情况仍存在差异,需要临床上予以重视。 展开更多
关键词 多发性骨髓瘤 ISS分期 R-ISS分期 预后价值 局限性
暂未订购
14例慢性淋巴细胞白血病合并自身免疫性溶血性贫血患者的临床特征及预后分析 被引量:4
3
作者 孙秀娟 陈佳雯 +5 位作者 王婷玉 王齐 阎禹廷 熊文婕 邱录贵 易树华 《中国肿瘤临床》 CAS CSCD 北大核心 2022年第20期1062-1066,共5页
目的:探讨慢性淋巴细胞白血病(chronic lymphocytic leukemia,CLL)合并自身免疫性溶血性贫血(autoimmune hemolytic anemia,AIHA)的临床特征、治疗方案及疗效。方法:回顾性分析1989年1月至2013年12月中国医学科学院血液病医院确诊的14例... 目的:探讨慢性淋巴细胞白血病(chronic lymphocytic leukemia,CLL)合并自身免疫性溶血性贫血(autoimmune hemolytic anemia,AIHA)的临床特征、治疗方案及疗效。方法:回顾性分析1989年1月至2013年12月中国医学科学院血液病医院确诊的14例CLL合并AIHA患者的临床资料。结果:14例CLL合并AIHA的患者中,其中男性11例,女性3例,中位年龄57.5(42.0~69.0)岁。B症状4例(28.6%),贫血9例(64.3%),乳酸脱氢酶(lactate dehydrogenase,LDH)增高10例(71.4%)。针对AIHA进行治疗后,14例患者中可评价疗效者9例,β2-微球蛋白水平增高9例(100%),免疫球蛋白重链可变区(immunoglobulin heavy chain variable region,IGHV)无突变3例(37.5%)。总有效(overall response rate,ORR)率为100%(9/9),完全缓解(complete response,CR)为6例(66.7%),部分缓解(partial response,PR)为3例(33.3%)。针对CLL进行治疗后,14例患者中可评价疗效者11例,ORR为63.6%(7/11),CR为3例(27.3%),PR为4例(36.4%),疾病稳定(stable disease,SD)为3例(27.3%),疾病进展(progressive disease,PD)为1例(9.1%)。有长期随访资料的11例患者中,中位无进展生存期(median progression-free survival,mPFS)为69(4~120)个月,中位总生存期(median overall survival,mOS)为75(4~128)个月。5年无进展生存(progression-free survival,PFS)率为(62.3±15.0)%,10年PFS率为(18.7±15.5)%,5年总生存(overall survival,OS)率为(80.0±12.6)%,10年OS率为(24.0±19.5)%。结论:AIHA为CLL的常见并发症,可在疾病不同阶段出现。糖皮质激素及美罗华联合化疗疗效较好,新型靶向药物具有良好的应用前景。 展开更多
关键词 自身免疫性溶血性贫血 慢性淋巴细胞白血病 利妥昔单抗 治疗结果
暂未订购
毛细胞白血病和毛细胞白血病变异型患者免疫球蛋白重链可变区基因分子特征分析 被引量:2
4
作者 王轶 王婷玉 +5 位作者 王君 阎禹廷 吕瑞 熊文婕 邱录贵 易树华 《中国肿瘤临床》 CAS CSCD 北大核心 2022年第20期1073-1078,共6页
目的:本研究归纳毛细胞白血病(hairy cell leukemia,HCL)和毛细胞白血病变异型(hairy cell leukemia-variant,HCL-v)患者免疫球蛋白重链可变区(immunoglobulin heavy chain variable region,IGHV)基因分子特征,并探讨其与临床特征及预... 目的:本研究归纳毛细胞白血病(hairy cell leukemia,HCL)和毛细胞白血病变异型(hairy cell leukemia-variant,HCL-v)患者免疫球蛋白重链可变区(immunoglobulin heavy chain variable region,IGHV)基因分子特征,并探讨其与临床特征及预后的相关性。方法:回顾性分析2004年12月至2020年1月在中国医学科学院血液病医院完善IGHV检测的29例HCL患者和15例HCL-v患者临床和生存资料。结果:44例患者共检测出23种重排片段,VH4和VH4-34分别是两种疾病最常见的V区基因家族和重排片段。HCL和HCL-v患者中IGHV为突变状态的比例分别为72.4%和66.7%,发生VH4-34重排(VH4-34 rearrangement,VH4-34+)的患者IGHV突变率更低(P<0.001)。在HCL中,使用VH1基因家族患者脾大发生率更低(P=0.041);而VH4-34+或IGHV未突变状态(IGHV-unmutated,IGHV-UM)的患者具有更高的乳酸脱氢酶(VH4-34+P=0.049,IGHV-UM P=0.022)和β2微球蛋白(VH4-34+P=0.039,IGHV-UM P=0.036)水平,且VH4-34+患者BRAF V600E突变率更低(20%vs.85%,P=0.012)。单因素预后分析显示,VH4-34+是HCL患者无进展生存(progression-free survival,PFS)(P=0.001)和总生存(P=0.004)的不良预后因素,IGHV-UM则为HCL-v患者PFS(P=0.038)的危险因素。结论:HCL和HCL-v患者对VH4基因家族及VH4-34存在偏向性使用,VH4-34+和IGHV-UM间存在明显共现性。在HCL中,VH4-34+与高肿瘤负荷及更差生存相关,而IGHV-UM是HCL-v患者PFS的危险因素。 展开更多
关键词 毛细胞白血病 毛细胞白血病变异型 免疫球蛋白重链可变区基因 疾病特征 预后
暂未订购
双克隆淋巴浆细胞淋巴瘤5例报道并文献复习 被引量:1
5
作者 黄燕姗 于颖 +6 位作者 熊文婕 阎禹廷 王婷玉 吕瑞 王齐 邱录贵 易树华 《中国肿瘤临床》 CAS CSCD 北大核心 2023年第12期601-605,共5页
目的探讨双克隆型淋巴浆细胞淋巴瘤(lymphoplasmacytic lymphoma,LPL)的临床特征及诊疗疗效。方法收集1993年6月至2017年10月就诊于中国医学科学院血液病医院5例双克隆型LPL患者的临床资料并进行分析。结果5例患者中男性4例、女性1例。... 目的探讨双克隆型淋巴浆细胞淋巴瘤(lymphoplasmacytic lymphoma,LPL)的临床特征及诊疗疗效。方法收集1993年6月至2017年10月就诊于中国医学科学院血液病医院5例双克隆型LPL患者的临床资料并进行分析。结果5例患者中男性4例、女性1例。3例为华氏巨球蛋白血症国际预后指数(ISSWM)分期高危患者,4例患者表达免疫球蛋白G(IgG)和免疫球蛋白M(IgM),3例患者表达不同类型轻链。5例患者的血清免疫固定电泳均为双克隆,骨髓均可见异常淋巴细胞及浆细胞浸润。5例患者确诊双克隆LPL后,2例CD20阳性者接受利妥昔单抗为基础的化疗方案、1例伊布替尼口服治疗、1例苯达莫司汀治疗效果不佳改用沙利度胺+地塞米松+环磷酰胺(TCD)治疗、1例使用司莫司汀+环磷酰胺+马法兰+地塞米松+长春新碱(M2)化疗。5例患者中4例达到微小缓解(minimal response,MR)及以上疗效,中位随访时间为44.1个月,中位无进展生存期(median progression-free survival,mPFS)为52.4个月,中位总生存期(median overall survival,mOS)为52.4个月。截至2022年5月随访结束,2例患者部分缓解(partial response,PR),2例患者死亡。结论双克隆LPL非常罕见,对该疾病的临床特征、诊断、治疗转归及预后尚缺乏深刻一致的认识,仍需更多的临床病例总结分析。 展开更多
关键词 淋巴浆细胞淋巴瘤 双克隆淋巴浆细胞淋巴瘤 华氏巨球蛋白血症 免疫固定电泳
暂未订购
光伏发电出力特征提取及区域集群聚合特性 被引量:7
6
作者 苏适 陆海 +1 位作者 严玉廷 杨家全 《云南电力技术》 2018年第1期86-94,共9页
研究光伏电站及其集群聚合的出力特性是实现光伏功率分类建模预测和区域光伏集群划分的前提和基础,对促进区域电网大规模光伏发电的充分消纳具有重要作用。以单个光伏电站与区域光伏发电集群为对象,从光伏发电出力特征提取与区域光伏集... 研究光伏电站及其集群聚合的出力特性是实现光伏功率分类建模预测和区域光伏集群划分的前提和基础,对促进区域电网大规模光伏发电的充分消纳具有重要作用。以单个光伏电站与区域光伏发电集群为对象,从光伏发电出力特征提取与区域光伏集群聚合特性分析两个层面开展研究。首先在分析大量光伏发电出力数据基础上,针对单个光伏电站的出力特征,分别提出三个整体性指标来刻画光伏出力曲线的总体形状和两个局部性指标来进一步精细化描述不同时间段的具体出力特点;其次,针对区域集群光伏电站定义了平滑效应系数量化光伏电站集群聚合后的平滑效应,提出了不一致性系数来表征平滑效应的产生机理;然后建立了平滑效应系数与区域电站个数、集群区域直径之间的多项式关系模型;利用云南某地区多个光伏电站大量实测数据的仿真结果表明,不仅提取的特征能较为准确刻画单个光伏电站的出力特点,提出的区域聚合分析模型还可进一步精确量化描述区域光伏集群的整体聚合特性。 展开更多
关键词 特征提取 集群聚合 平滑效应 不一致性系数
在线阅读 下载PDF
考虑光伏并网不确定性的需求侧分时电价运营策略 被引量:4
7
作者 陆海 苏适 +2 位作者 陈晓云 严玉廷 杨家全 《云南电力技术》 2018年第2期96-102,共7页
针对分布式光伏电源并网对配电网源荷运行特性的影响,本文首先结合消费心理学分析了用户需求对分时电价的响应特性,接着研究了统计配电网供给侧运营成本效益,以及描述光伏电源并网输出不确定性的数学模型。在此基础上,基于模糊机会约束... 针对分布式光伏电源并网对配电网源荷运行特性的影响,本文首先结合消费心理学分析了用户需求对分时电价的响应特性,接着研究了统计配电网供给侧运营成本效益,以及描述光伏电源并网输出不确定性的数学模型。在此基础上,基于模糊机会约束理论,提出了配电网考虑分布式电源并网不确定性和需求侧可中断负荷的分时电价优化运营模型,进而结合机会约束等式和粒子群优化算法,研究了所提电价优化运营模型的求解方法,最后论证了所提电价运营策略的可行性。 展开更多
关键词 需求响应 需求侧管理 峰谷分时电价 模糊机会约束 粒子群优化
在线阅读 下载PDF
功率与负荷预测的智能建筑双时间尺度多能互补优化模型 被引量:3
8
作者 苏适 陆海 +1 位作者 严玉廷 杨家全 《云南电力技术》 2018年第2期116-124,共9页
建筑光伏(Building Integrated Photovoltaic,BIPV)发电功率出力的随机波动特性,新型负荷与传统负荷的相互作用、需求侧响应和分时电价对负荷特性的影响是智能建筑能量管理系统(Energy Management System,EMS)优化运行必须考虑且亟待解... 建筑光伏(Building Integrated Photovoltaic,BIPV)发电功率出力的随机波动特性,新型负荷与传统负荷的相互作用、需求侧响应和分时电价对负荷特性的影响是智能建筑能量管理系统(Energy Management System,EMS)优化运行必须考虑且亟待解决的突出问题。以BIPV功率、负荷功率与温度预测为基础,综合考虑系统整体的经济性与用户舒适度,联合日前、日内两个时间尺度建立了智能建筑EMS的两阶段优化模型。日前尺度计及分时电价,以系统运行经济性为目标,制定可控电源机组启停、可平移负荷、储能装置的优化运行方案;日内尺度则在日前优化基础上综合平衡系统经济性和用户舒适度,对可控电源功率及可控负荷功率进行滚动优化。最后通过实际数据的算例仿真验证了本文所提模型的有效性。 展开更多
关键词 需求响应 需求侧管理 峰谷分时电价 模糊机会约束 粒子群优化
在线阅读 下载PDF
Optimal Structural Parameters for a Plastic Centrifugal Pump Inducer
9
作者 Wenbin Luo Lingfeng Tang +1 位作者 yuting yan Yifang Shi 《Fluid Dynamics & Materials Processing》 EI 2023年第4期869-899,共31页
The aim of the study is to determine the optimal structural parameters for a plastic centrifugal pump inducer within the framework of an orthogonal experimental method.For this purpose,a numerical study of the related... The aim of the study is to determine the optimal structural parameters for a plastic centrifugal pump inducer within the framework of an orthogonal experimental method.For this purpose,a numerical study of the related flow field is performed using CFX.The shaft power and the head of the pump are taken as the evaluation indicators.Accordingly,the examined variables are the thickness(S),the blade cascade degree(t),the blade rim angle(β1),the blade hub angle(β2)and the hub length(L).The impact of each structural parameter on each evaluation index is examined and special attention is paid to the following combinations:S2 mm,t 2,β1235°,β2360°and L 140 mm(corresponding to a maximum head of 98.15 m);S 5 mm,t 1.6,β1252°,β2350°and L 140 mm(corresponding to a minimum shaft power of 63.06 KW).Moreover,using least squares and fish swarm algorithms,the pump shaft power and head are further optimized,yielding the following optimal combination:S 5 mm,t 1.9,β1252°,β2360°and L 145 mm(corresponding to the maximum head of 91.90 m,and a minimum shaft power of 64.83 KW). 展开更多
关键词 Plastic centrifugal pump INDUCER cascade degree shaft power parameter optimization
在线阅读 下载PDF
Optimization of the Structural Parameters of a Plastic Centrifugal Pump in the Framework of a Flow Field Analysis
10
作者 Wenbin Luo Youmin Wang +2 位作者 yuting yan Yifang Shi Zhendong Zhang 《Fluid Dynamics & Materials Processing》 EI 2022年第3期789-813,共25页
In order to determine the optimal structural parameters of a plastic centrifugal pump in the framework of an orthogonal-experiment approach,a numerical study of the related flow field has been performed using CFX.The ... In order to determine the optimal structural parameters of a plastic centrifugal pump in the framework of an orthogonal-experiment approach,a numerical study of the related flow field has been performed using CFX.The thickness S,outlet angleβ2,inlet angleβ1,wrap angle,and inlet diameter D1 of the splitter blades have been considered as the variable factors,using the shaft power and efficiency of the pump as evaluation indices.Through a parametric analysis,the relative importance of the influence of each structural parameter on each evaluation index has been obtained,leading to the following combinations:β119°,β235°,S 2 mm,wrap angle 154°,and D185 mm(corresponding to the maximum efficiency of 75.48%);β119°,β220°,S 6 mm,wrap angle 158°,and D181 mm(corresponding to the minimum shaft power of 75.48%).Moreover,the grey correlation method has been applied to re-optimize the shaft power and efficiency of the pump,leading to the following optimal combination:β119°,β215°,S 4 mm,D181 mm,and wrap angle 152°(corresponding to the maximum efficiency of 71.81%and minimum shaft power of 2.187 kW). 展开更多
关键词 Plastic centrifugal pump splitter blade orthogonal experiment grey correlation method optimal combination
在线阅读 下载PDF
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia:a multicenter phaseⅡstudy
11
作者 Ying Yu Yuxi Li +23 位作者 Rui Cui yuting yan Fei Li yan Chen Tingyu Wang Xiaoli Hu Yaqing Feng Tengteng Yu yanshan Huang Jingwen Sun Rui Lyu Wenjie Xiong Qi Wang Wei Liu Gang An Weiwei Sui yan Xu Wenyang Huang Dehui Zou Huijun Wang Zhijian Xiao Jianxiang Wang Lugui Qiu Shuhua Yi 《Signal Transduction and Targeted Therapy》 2025年第4期2346-2353,共8页
Large granular lymphocytic leukemia(LGLL)is characterized by the clonal proliferation of cytotoxic T lymphocytes or NK cells.Standard first-line immunosuppressive treatments have limitations,achieving complete remissi... Large granular lymphocytic leukemia(LGLL)is characterized by the clonal proliferation of cytotoxic T lymphocytes or NK cells.Standard first-line immunosuppressive treatments have limitations,achieving complete remission(CR)rates of up to 50%.Immune system dysregulation is implicated in LGLL.Promising results for thalidomide,an immunomodulatory drug,combined with prednisone and methotrexate(TPM),were observed in our pilot study.This multicenter study evaluated the effcacy and safety of a thalidomide,prednisone,and methotrexate(TPM)regimen in 52 symptomatic,methotrexate-and thalidomide-naive LGLL patients from June 2020 to August 2022.Thalidomide(100 mg daily for up to 24 months),prednisone(0.5-1.0 mg/kg every other day,tapered after 3 months),and methotrexate(10 mg/m^(2) weekly for up to 12 months)were administered.The primary objective was to determine the CR rate.The median follow-up duration was 29.0 months(range:4.0-42.0).Forty-seven patients(90.4%)achieved hematological and symptomatic responses.Thirty-nine patients(75.0%)achieved CR.The median time to response was 3.0 months(range:3.0-9.0).The median progression-free survival was 40.0 months(95%confidence interval(Cl):38.0-42.0),and the median duration of response was 39.0 months(95%Cl:36.1-41.9).The most common adverse event was peripheral neuropathy(24.1%),most of which(84.6%)were grades 1-2.Four patients experienced grade≥3 adverse events.In conclusion,the TPM regimen was an effective and safe treatment for symptomatic LGLL patients,with a particularly high CR rate.This trial was registered at www.clinicaltrials.gov(#NCT04453345). 展开更多
关键词 large granular lymphocytic leukemia lgll PREDNISONE clonal proliferation cytotoxic t lymphocytes immunomodulatory drugcombined Large Granular Lymphocytic Leukemia system dysregulation multicenter study THALIDOMIDE
暂未订购
Microsecond-Scale Transient Thermal Sensing Enabled by Flexible Mo_(1−x)W_(x)S_(2) Alloys
12
作者 Weiwei Li Lingyan Kong +16 位作者 Manzhang Xu Jiuwei Gao Lei Luo Yingzhe Li Kexin Wang Yilin Zhou Lei Li Yuan Wei Xiaoshan Zhang Ruoqing Zhao Mengdi Chen yuting yan Xiaoguang Luo Zhaohe Dai Lu Zheng Xuewen Wang Wei Huang 《Research》 2025年第3期196-208,共13页
Real-time thermal sensing through flexible temperature sensors in extreme environments is critically essential for precisely monitoring chemical reactions,propellant combustions,and metallurgy processes.However,despit... Real-time thermal sensing through flexible temperature sensors in extreme environments is critically essential for precisely monitoring chemical reactions,propellant combustions,and metallurgy processes.However,despite their low response speed,most existing thermal sensors and related sensing materials will degrade or even lose their sensing performances at either high or low temperatures.Achieving a microsecond response time over an ultrawide temperature range remains challenging.Here,we design a flexible temperature sensor that employs ultrathin and consecutive Mo_(1−x)W_(x)S_(2) alloy films constructed via inkjet printing and a thermal annealing strategy.The sensing elements exhibit a broad work range(20 to 823 K on polyimide and 1,073 K on flexible mica)and a record-low response time(about 30μs).These properties enable the sensors to detect instantaneous temperature variations induced by contact with liquid nitrogen,water droplets,and flames.Furthermore,a thermal sensing array offers the spatial mapping of arbitrary shapes,heat conduction,and cold traces even under bending deformation.This approach paves the way for designing unique sensitive materials and flexible sensors for transient sensing under harsh conditions. 展开更多
关键词 real time thermal sensing thermal sensors sensing materials flexible te chemical reactionspropellant combustionsand thermal sensing microsecond scale transient thermal sensing flexible Mo_(1−x)W_(x)S_(2)alloys
原文传递
Two-color emissive AIEgens with anti-Kasha property for dual-organelle imaging and phototherapy 被引量:2
13
作者 Pu Chen Guogang Shan +5 位作者 Qingli Nie yuting yan Pengfei Zhang Zujin Zhao Hai-Tao Feng Ben Zhong Tang 《Science China Chemistry》 SCIE EI CAS CSCD 2024年第5期1740-1752,共13页
Despite the rapid development of probes for targeting single organelle, the construction of robust dual-organelle targeting probes with multicolor emission was rarely reported. Herein, two dual-emissive aggregation-in... Despite the rapid development of probes for targeting single organelle, the construction of robust dual-organelle targeting probes with multicolor emission was rarely reported. Herein, two dual-emissive aggregation-induced emission luminogens(AIEgens)with donor-π-acceptor structures were designed and synthesized, namely QT-1 and QF-2. Both two AIEgens exhibited excitation wavelength-dependence defying the Kasha's rule, and could stain lipid droplets(LDs) and mitochondria in blue and red fluorescence, respectively. Moreover, thanks to the near-infrared emission and abundant reactive oxygen species(ROS) generation efficiency of QT-1, it was chosen as a photodynamic therapy agent to selectively kill cancer cells from normal cells. Upon light irradiation, an obvious decrease of mitochondrial membrane potential(MMP) and serious change of mitochondrial shape in cells were observed, which corresponded to the efficient inhibition of tumor growth in vivo. This work afforded a promising strategy for the construction of multicolor emission by tuning anti-Kasha behaviors and expanding their application in dualorganelle targeting-based phototheranostics. 展开更多
关键词 aggregation-induced emission anti-Kasha luminescence fluorescent probe BIOIMAGING photodynamic therapy
原文传递
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma 被引量:1
14
作者 Ru Li Tingyu Wang +16 位作者 Rui Lyv Yi Wang Ying Yu yuting yan Qi Sun Wenjie Xiong Wei Liu Weiwei Sui Wenyang Huang Huijun Wang Chengwen Li Jun Wang Dehui Zou Gang An Jianxiang Wang Lugui Qiu Shuhua Yi 《Blood Science》 2023年第2期118-124,共7页
Rituximab maintenance(RM)prolongs the progression-free survival(PFS)of responding patients with follicular lymphoma(FL),but the maintenance efficacy in different Follicular Lymphoma International Prognostic Index(FLIP... Rituximab maintenance(RM)prolongs the progression-free survival(PFS)of responding patients with follicular lymphoma(FL),but the maintenance efficacy in different Follicular Lymphoma International Prognostic Index(FLIPI)risk group is still confusing.We performed a retrospective analysis of the effect of RM treatments in patients with FL responding to induction therapy based on their FLIPI risk assessment carried out prior to treatment.We identified 93 patients between 2013 and 2019 who received RM every 3 months for≥4 doses(RM group),and 60 patients who did not accept RM or received rituximab less than 4 doses(control group).After a median follow-up of 39 months,neither median overall survival(OS)nor PFS was reached for the entire population.The PFS was significantly prolonged in the RM group compared to the control group(median PFS NA vs 83.1 months,P=.00027).When the population was divided into the 3 FLIPI risk groups,the PFS differed significantly(4-year PFS rates,97.5%vs 88.8%vs 72.3%,P=.01)according to group.There was no significant difference in PFS for FLIPI low-risk patients with RM compared to the control group(4-year PFS rates,100%vs 93.8%,P=.23).However,the PFS of the RM group was significantly prolonged for FLIPI intermediate-risk(4-year PFS rates,100%vs 70.3%,P=.00077)and high-risk patients(4-year PFS rates,86.7%vs 57.1%,P=.023).These data suggest that standard RM significantly prolongs the PFS of patients assigned to intermediate-and high-risk FLIPI groups but not to low-risk FLIPI group,and pending larger-scale studies to validate. 展开更多
关键词 Follicular lymphoma Follicular lymphoma international prognostic index Induction therapy Maintenance Progressionfree survival RITUXIMAB
原文传递
Highly sensitive detection of daminozide using terahertz metamaterial sensors
15
作者 Hanping Mao Xiaoxue Du +7 位作者 yuting yan Xiaodong Zhang Guoxin Ma Yafei Wang Yong Liu Bin Wang Xiaoyue yang Qiang Shi 《International Journal of Agricultural and Biological Engineering》 SCIE CAS 2022年第6期180-188,共9页
In order to solve the problems of low sensitivity and complex sample pretreatment in traditional detection,a method was proposed in this study to detect daminozide using terahertz combined with a metamaterial sensor,w... In order to solve the problems of low sensitivity and complex sample pretreatment in traditional detection,a method was proposed in this study to detect daminozide using terahertz combined with a metamaterial sensor,which enables real-time and label-free molecular detection with high sensitivity.The correlation between the transmission frequency shift and absorbance of daminozide solution at different concentrations was analyzed.The simulation and experimental results showed that this metamaterial sensor could achieve highly sensitive sensing of daminozide solutions at 0.05 mg/L.The maximum quality factor(Q_(max))of the two peaks could reach 5.78 and 13.05,and the maximum figure of merit(FOM)of the two peaks can reach 0.82 and 1.72.The maximum sensitivity of two resonance peaks reached 38.148 GHz/(mg·L)and 133.516 GHz/(mg·L)when the concentration of daminozide in the solution was 2000 mg/L.There was an obvious positive correlation between the transmission and transmission,frequency shift and frequency shift,and absorbance and absorbance of the resonance peak of daminozide solutions.Therefore,this platform not only opens up new possibilities for the microanalysis of the chemical composition of substances in solutions but also provides a valuable reference for the design of other metamaterial-based sensors in the field of food safety. 展开更多
关键词 Terahertz time-domain spectroscopy plant growth regulator DETECTION METAMATERIAL
原文传递
High pressure phase boundaries of AgNbO_(3)
16
作者 Kai Dai Anyang Cui +9 位作者 Yafang Li Zhen Liu yuting yan Kai Jiang Jinzhong Zhang Liyan Shang Liangqing Zhu Yawei Li Genshui Wang Zhigao Hu 《Journal of Materiomics》 SCIE CSCD 2024年第2期431-439,共9页
The external pressure is one of the essential parameters for regulating the structure and energy con-version properties of antiferroelectric AgNbO_(3).For pure AgNbO_(3),however,there has been still a blank of its rea... The external pressure is one of the essential parameters for regulating the structure and energy con-version properties of antiferroelectric AgNbO_(3).For pure AgNbO_(3),however,there has been still a blank of its real lattice structure under the stress field.Here,high-pressure lattice structures and phase transitions of AgNbO_(3)have been explored by spectroscopic experiments and theoretical models.A successive phase transition process from Pbcm to C222_(1) to P2_(1) has been observed at the pressure range of 0-30 GPa,associated with displacive-type characterized by soft-mode kinetics.Note that the paraelectric phase cannot be achieved under high-pressure at room temperature.Significantly,the competition of long-range Coulomb force,short-range interatomic interaction,and covalent interaction in AgNbO_(3)lattice were demonstrated under the stress field.The present work can provide fundamental guidelines to reveal the high-pressure phase transitions of AgNbO_(3),which will open up possibilities for the designing device with functional properties at extremes. 展开更多
关键词 TEMPERATURE FIELD PHASE
原文传递
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
17
作者 Ying Yu Wenjie Xiong +12 位作者 Tingyu Wang yuting yan Rui Lyu Qi Wang Wei Liu Gang An Weiwei Sui yan Xu Wenyang Huang Dehui Zou Jianxiang Wang Lugui Qiu Shuhua Yi 《Blood Science》 2024年第1期1-7,共7页
Waldenstrom macroglobulinemia(WM)is a type of incurable,indolent B-cell lymphoma that is prone to relapse.Over time,treatment strategies have progressed from cytotoxic drugs to rituximab(R)-or bortezomib(V)-based regi... Waldenstrom macroglobulinemia(WM)is a type of incurable,indolent B-cell lymphoma that is prone to relapse.Over time,treatment strategies have progressed from cytotoxic drugs to rituximab(R)-or bortezomib(V)-based regimens,and have now entered into an era of Bruton tyrosine kinase inhibitor(BTKi)-based regimens.However,the optimal treatment for the relapsed patients is still unclear.Herein,we analyzed the outcomes of the first-and second-line therapies in 377 patients with WM to illustrate the optimal choices for second-line therapy.After a median follow-up of 45.4 months,89 patients received second-line therapy,and 53 patients were evaluated for response.The major response rates(MRR)of first-and second-line treatment were 65.1%and 67.9%(P=0.678).The median progression-free survival(PFS)for the second-line therapy(PFS2)was shorter than that for the first-line therapy(PFS1)(56.3 vs 40.7 months,P=0.03).However,PFS2 in targeted drugs group(R-/V-/BTKi-based regimens)was comparable to PFS1(60.7 months vs 44.7 months,respectively,P=0.21).Regarding second-line therapy,patients who underwent sequential treatment escalation—such as transitioning from cytotoxic drugs to R-/V-/BTKi-based regimens or from R-/V-based to BTKi-based regimens(escalation group)—had higher MRR(80.6%vs 47.1%,respectively,P=0.023)and longer PFS2(50.4 vs 23.5 months,respectively,P<0.001)compared to the non-escalation group.Patients in the escalation group also had longer post-relapse overall survival compared with the non-escalation group(median,not reached vs 50.7 months,respectively,P=0.039).Our findings indicate that sequential treatment escalation may improve the survival of patients with WM. 展开更多
关键词 PROGNOSIS RELAPSE Treatment options Waldenstrom macroglobulinemia
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部